Oct 5, 2020
SAN DIEGO, Oct. 5, 2020 /PRNewswire/ -- AVACEN Medical (AVACEN) announced the completion and results from the second part of its sponsored 50 person study of glucose tolerance in Type 2 diabetics.
The double-blind randomized controlled pilot study with crossover design focused on postprandial blood glucose (PBG) reduction consequential to use of the AVACEN 100 dry heat therapy medical device. The AVACEN device is believed to have the ability to overcome disease-induced microvascular impairment by mechanically recruiting the microvasculature allowing for glucose disposal. PBG is an independent predictor of all-cause mortality, cardiovascular disease and cardiac events.
Furthermore, recent 3rd party research has revealed that diabetes is associated with greater pulmonary inflammation and that successful blood glucose management is effective in fighting serious cases of COVID-19.
The IRB approved study was conducted in the Clinical Nutrition and Physiological Sciences Laboratory in conjunction with The School of Exercise and Nutritional Sciences at San Diego State University. Michael J. Buono, Ph.D., Professor School of Exercise and Nutritional Sciences and the Department of Biology acted as Principal Investigator.
According to diabetes researcher Jonathan RT Lakey, PhD, MSM, professor of surgery and biomedical engineering at UC Irvine: "The SDSU study demonstrates that the AVACEN negative pressure heat treatment may overcome microvascular damage caused by Type 2 diabetes. They also show significant reductions in lowering post prandial blood glucose compared to non-treated controls. I look forward to further evaluation of this device in larger series of patients, both Type 2 diabetics as well as long standing insulin dependent Type 1 diabetic patients."
Type 2 diabetes currently constitutes a global crisis. It stands as a leading cause of both death and disability in countries of all income levels, directly costing nearly a trillion dollars to the world.
While it's largely considered a preventable and reversible disease, Type 2 diabetics continues to increase in prevalence in individuals of all ages. Even though exercise and diet are effective in lowering blood glucose, adherence is often poor. Globally, one in three women and one in four men do not meet the physical activity guidelines.
According to Thomas G. Muehlbauer, AVACEN Medical CEO; "One of the most exciting aspects is that the study suggests that the AVACEN device may also offer a convenient treatment for lowering postprandial blood glucose which supports adherence. Due to this ease of use, we see many Type 2 diabetics conscientiously following our twice daily 20-minute AVACEN protocol for the temporary relief of minor muscle and joint pain. The unexpected benefit is a significant reduction in their A1C in only a few months. Therefore, we are planning a 13-week study to scientifically document this powerful aspect in support of an FDA request to increase our approved indications of use to include reducing A1C."
About SDSU and the School of Exercise and Nutritional Sciences
Founded in 1897, San Diego State University is a public institution of higher education located in southern California. SDSU is the oldest and largest university in San Diego and the third largest in the state.
The School of Exercise and Nutritional Sciences (ENS) at SDSU has evolved from its beginnings in 1914 as a physical education department to one that now offers undergraduate degrees in kinesiology, foods and nutrition, and athletic training; master's degrees in exercise physiology, kinesiology, and nutrition; and a doctor of physical therapy.
About AVACEN Medical
AVACEN Medical is dedicated to the innovation and design of safe, easy to use, noninvasive drug-free alternatives for the management of pain associated with numerous chronic and acute conditions including the temporary relief of minor muscle and joint pain and stiffness associated with arthritis and potentially other conditions that can cause joint pain, such as CRPS, Reynaud's, and Lyme Disease. Founded in 2009, AVACEN Medical is headquartered in Carlsbad, CA. Contact: Thomas Muehlbauer at (888) 428-2236 x 701 or
[email protected]
.
SOURCE AVACEN, Inc
Related Links
The Raman campaign's complaint says the ads spread on social media steer viewers to an interactive AI phone line with a voice falsely identified as that of Nithya Raman.
Measure PFD on the ballot in Pasadena would levy an annual parcel tax of 19 cents per square foot of improved property, with exemptions for low-income homeowners. The money would go into a special fund earmarked for fire stations, apparatus, equipment and staffing.
A former Bass advisor now runs an outside campaign committee supporting her reelection, raising questions about whether the committee is truly independent.
Lawyers for the Justice Department managed to get a three-judge panel to convene a rare emergency hearing on Sunday.
Seawater levels could reach near-record or record heights along Southern California, the National Weather Service warned. The highest high tides are expected Monday, Tuesday and Wednesday.
In my suburb, rare orange-bellied parrots get more attention than real estate developers – and the locals love it that way.
A former Royal Australian Air Force pilot accused of murder lived a double life and killed his wife so he would not lose millions of dollars in a divorce, a court has heard.
Live coverage of the SMH Good Food Guide Awards ceremony at Carriageworks.
The man was found dead after going missing in floodwater north of Brisbane, as warnings were issued for the Lockyer Valley and Darling Downs.
The 46-year-old has been refused bail charged with child grooming and abuse material offences.
The family of missing Melbourne grandmother Janet Knight has issued a plea for help after the 73-year-old vanished from her home.
A 21-year-old man shot by police following reports of domestic violence in Sydney’s south-west has been charged from his hospital bed.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.